Opyl, the global leader in AI-driven biostatistical validation and an ASX-listed company (ASX: OPL), is transforming clinical trial designs through its advanced simulation platform, TrialKey. Tailored for Clinical Research Organisations (CROs), pharmaceutical companies, and trial sponsors, Opyl enhances success probabilities across all phases of clinical research, delivering comprehensive global trial design solutions. Key features include the TrialGen module, which offers data-backed recommendations on study type, enrolment numbers, inclusion/exclusion criteria, endpoints, and optimal trial durations. Opyl’s simulation capabilities also refine intervention models, masking types, and resource allocation, reducing costly amendments and accelerating market entry, providing a competitive advantage in clinical research. With market-leading accuracy, Opyl’s platform achieves over 92% in forecasting trial completion. By simulating each trial 10,000 times, it delivers robust, data-driven biostatistical validation to optimise designs. The platform analyses extensive datasets from over 350,000 clinical trials and 1300+ variables, offering critical insights for strategic planning and decision-making, including competitor benchmarking and success probability distributions. Globally applicable and scalable, Opyl supports companies of all sizes, from small firms managing a few trials to large organisations running thousands. Its user-friendly design and comprehensive support empower clinicians, researchers, and investors to make informed decisions, streamline trial outcomes, and advance medical research.

Website: https://opyl.ai/

Employees: 20 - 49

HQ: N/A

Location: St Kilda, Victoria, AU

Revenue: $5.7 million

Opyl Ltd is a leading provider of AI-powered lead generation solutions. With millions of companies across the globe, ConnectPlex.ai is the ideal platform to connect with professionals working at Opyl Ltd. Our advanced search filters and company information help you find the right contact details quickly and easily. Reach out to key decision-makers and grow your business with ConnectPlex. At ConnectPlex.ai, we understand the importance of accurate and up-to-date contact information. Our team works tirelessly to ensure that our database is constantly updated and verified. With our platform, you can easily find contact details for Opyl Ltd and other companies, and grow your business network. Start your search today and connect with the right people at Opyl Ltd.

Opyl Ltd is a cutting-edge technology consulting company that specializes in providing AI-assisted solutions to the healthcare industry. Located in St Kilda, Australia, the company boasts a team of experts who are dedicated to helping leading biopharma and health organizations improve the design, development, and delivery of their services. With a strong focus on innovation and professional guidance, Opyl is revolutionizing the way healthcare is delivered. As a publicly listed company on the ASX, Opyl has established itself as a leader in the technology consulting industry. With a revenue of $1-2.5 million and a team of 20-49 employees, the company is committed to providing tailored solutions that meet the unique needs of its clients. Whether it's helping to understand complex data or streamlining processes, Opyl's AI-assisted technologies are designed to make a real difference in the healthcare industry. With a strong presence on LinkedIn and a website that showcases their services, Opyl is a company that is definitely worth keeping an eye on.

Opyl is a company that helps other companies in the healthcare industry use artificial intelligence (AI) to improve the way they work. They provide technology and expert advice to help these companies design, develop, and deliver better healthcare services. Opyl is a publicly traded company, which means its shares can be bought and sold on the Australian Securities Exchange (ASX). Its stock symbol is OPL.